ArticleJournal of neurosurgery. Case lessons2025
Genomic analysis revealing Lynch syndrome in a case of high-grade glioma: illustrative case.
Article in Journal of neurosurgery. Case lessons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdvances in cancer genome analysis technology have made individual cancer genome profiling (CGP) possible. CGP can indicate the presence of hereditary tumors, which are caused by germline pathogenic variants in oncogenes or tumor suppressor genes; if a hereditary tumor is suspected, multigene panel testing (MGPT) is performed. Genomic medicine thus plays an important role in diagnosing hereditary tumors. OBSERVATIONS: A 41-year-old man presented with headache and depressive symptoms. Close examination revealed a mass lesion with cystic components in the right parietal lobe. The tumor was removed via craniotomy and was pathologically diagnosed as a high-grade glioma. CGP of the tumor area revealed a high tumor mutation burden and multiple presumed germline pathogenic variants. MGPT of peripheral blood detected a germline pathogenic variant in MSH6. The patient was therefore diagnosed with Lynch syndrome. LESSONS: Family history and genetic risk assessments, including CGP, are important for diagnosing genetic diseases. Next-generation sequencing technology is essential for genetic analyses, and if many genetic mutations are identified using tumor-only CGP, MGPT of peripheral blood is an efficient option. In addition, MSH6 variant analysis is important for diagnosing Lynch syndrome and determining treatment. In particular, functional analysis of somatic variants is essential for understanding disease associations. https://thejns.org/doi/10.3171/CASE24718.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.